241 related articles for article (PubMed ID: 38194517)
21. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
[TBL] [Abstract][Full Text] [Related]
22. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
[TBL] [Abstract][Full Text] [Related]
23. New Approaches for Biomonitoring Exposure to the Human Carcinogen Aristolochic Acid.
Yun BH; Sidorenko VS; Rosenquist TA; Dickman KG; Grollman AP; Turesky RJ
Toxicol Res (Camb); 2015 Jul; 4(4):763-776. PubMed ID: 26366284
[TBL] [Abstract][Full Text] [Related]
24. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
[TBL] [Abstract][Full Text] [Related]
25. Aristolochic acid exposure in Romania and implications for renal cell carcinoma.
Turesky RJ; Yun BH; Brennan P; Mates D; Jinga V; Harnden P; Banks RE; Blanche H; Bihoreau MT; Chopard P; Letourneau L; Lathrop GM; Scelo G
Br J Cancer; 2016 Jan; 114(1):76-80. PubMed ID: 26657656
[TBL] [Abstract][Full Text] [Related]
26. Multiclass Carcinogenic DNA Adduct Quantification in Formalin-Fixed Paraffin-Embedded Tissues by Ultraperformance Liquid Chromatography-Tandem Mass Spectrometry.
Guo J; Yun BH; Upadhyaya P; Yao L; Krishnamachari S; Rosenquist TA; Grollman AP; Turesky RJ
Anal Chem; 2016 May; 88(9):4780-7. PubMed ID: 27043225
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
[TBL] [Abstract][Full Text] [Related]
28. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.
Hollstein M; Moriya M; Grollman AP; Olivier M
Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071
[TBL] [Abstract][Full Text] [Related]
29. Liquid chromatography-tandem mass spectrometry analysis of the DNA adducts of aristolochic acids.
Chan W; Zheng Y; Cai Z
J Am Soc Mass Spectrom; 2007 Apr; 18(4):642-50. PubMed ID: 17208007
[TBL] [Abstract][Full Text] [Related]
30. DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver.
Mei N; Arlt VM; Phillips DH; Heflich RH; Chen T
Mutat Res; 2006 Dec; 602(1-2):83-91. PubMed ID: 17010389
[TBL] [Abstract][Full Text] [Related]
31. Aristolochic acid and the etiology of endemic (Balkan) nephropathy.
Grollman AP; Shibutani S; Moriya M; Miller F; Wu L; Moll U; Suzuki N; Fernandes A; Rosenquist T; Medverec Z; Jakovina K; Brdar B; Slade N; Turesky RJ; Goodenough AK; Rieger R; Vukelić M; Jelaković B
Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12129-34. PubMed ID: 17620607
[TBL] [Abstract][Full Text] [Related]
32. Quantitation of DNA Adducts in Target and Nontarget Organs of Aristolochic Acid I-Exposed Rats: Correlating DNA Adduct Levels with Organotropic Activities.
Liu Y; Chan CK; Jin L; Wong SK; Chan W
Chem Res Toxicol; 2019 Mar; 32(3):397-399. PubMed ID: 30604963
[TBL] [Abstract][Full Text] [Related]
33. Aristolochic acid-associated urothelial cancer in Taiwan.
Chen CH; Dickman KG; Moriya M; Zavadil J; Sidorenko VS; Edwards KL; Gnatenko DV; Wu L; Turesky RJ; Wu XR; Pu YS; Grollman AP
Proc Natl Acad Sci U S A; 2012 May; 109(21):8241-6. PubMed ID: 22493262
[TBL] [Abstract][Full Text] [Related]
34. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.
Jelaković B; Karanović S; Vuković-Lela I; Miller F; Edwards KL; Nikolić J; Tomić K; Slade N; Brdar B; Turesky RJ; Stipančić Ž; Dittrich D; Grollman AP; Dickman KG
Kidney Int; 2012 Mar; 81(6):559-67. PubMed ID: 22071594
[TBL] [Abstract][Full Text] [Related]
35. The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats.
Stiborová M; Bárta F; Levová K; Hodek P; Frei E; Arlt VM; Schmeiser HH
Arch Toxicol; 2015 Nov; 89(11):2141-58. PubMed ID: 25209566
[TBL] [Abstract][Full Text] [Related]
36. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.
Stiborová M; Frei E; Breuer A; Wiessler M; Schmeiser HH
Mutat Res; 2001 Jun; 493(1-2):149-60. PubMed ID: 11516724
[TBL] [Abstract][Full Text] [Related]
37. A novel and specific method for the determination of aristolochic acid-derived DNA adducts in exfoliated urothelial cells by using ultra performance liquid chromatography-triple quadrupole mass spectrometry.
Guo L; Wu H; Yue H; Lin S; Lai Y; Cai Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(2):153-8. PubMed ID: 21177145
[TBL] [Abstract][Full Text] [Related]
38. Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid.
Jelaković B; Castells X; Tomić K; Ardin M; Karanović S; Zavadil J
Int J Cancer; 2015 Jun; 136(12):2967-72. PubMed ID: 25403517
[TBL] [Abstract][Full Text] [Related]
39. Aristolochic acid IVa forms DNA adducts in vitro but is non-genotoxic in vivo.
Wan J; Chen R; Yang Z; Xi J; Cao Y; Chen Y; Zhang X; Luan Y
Arch Toxicol; 2021 Aug; 95(8):2839-2850. PubMed ID: 34223934
[TBL] [Abstract][Full Text] [Related]
40. DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.
Stiborová M; Arlt VM; Schmeiser HH
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
